Herantis Pharma (Finland) Top Insiders
HRTIS Stock | EUR 1.64 0.01 0.61% |
Herantis Pharma employs about 13 people. The company is managed by 7 executives with a total tenure of roughly 14 years, averaging almost 2.0 years of service per executive, having 1.86 employees per reported executive. Assessment of Herantis Pharma's management performance can provide insight into the firm performance.
Henri Huttunen Executive Chief Scientific Officer |
Sigrid Booms Director Director of Clinical Development |
Herantis |
Herantis Pharma Management Team Effectiveness
The company has return on total asset (ROA) of (0.6005) % which means that it has lost $0.6005 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (13.3662) %, meaning that it generated substantial loss on money invested by shareholders. Herantis Pharma's management efficiency ratios could be used to measure how well Herantis Pharma manages its routine affairs as well as how well it operates its assets and liabilities.Herantis Pharma Workforce Comparison
Herantis Pharma Oyj is one of the top stocks in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 23,495. Herantis Pharma adds roughly 13.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Herantis Pharma Oyj Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Herantis Pharma Oyj Price Series Summation is a cross summation of Herantis Pharma price series and its benchmark/peer.
Herantis Pharma Notable Stakeholders
A Herantis Pharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Herantis Pharma often face trade-offs trying to please all of them. Herantis Pharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Herantis Pharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Sigrid Booms | Director of Clinical Development | Profile | |
Henri Huttunen | Chief Scientific Officer | Profile | |
Antti D | CEO COO | Profile | |
Jutta Poutanen | Chief Pharmaceutical Officer | Profile | |
Jani Koskinen | Project Manager | Profile | |
Outi MD | Chief Ofcer | Profile | |
Tone Kvale | Chief Officer | Profile |
About Herantis Pharma Management Performance
The success or failure of an entity such as Herantis Pharma Oyj often depends on how effective the management is. Herantis Pharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Herantis management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Herantis management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Herantis Pharma Oyj, a drug development company, focuses on developing regenerative therapeutics. The company was founded in 2008 and is based in Espoo, Finland. Herantis Pharma operates under Pharmaceuticals And Biosciences classification in Finland and is traded on Helsinki Exchange. It employs 13 people.
Herantis Pharma Workforce Analysis
Traditionally, organizations such as Herantis Pharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Herantis Pharma within its industry.Herantis Pharma Manpower Efficiency
Return on Herantis Pharma Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 982.1K | |
Net Loss Per Executive | 1.8M | |
Working Capital Per Employee | 384.6K | |
Working Capital Per Executive | 714.3K |
Complementary Tools for Herantis Stock analysis
When running Herantis Pharma's price analysis, check to measure Herantis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Herantis Pharma is operating at the current time. Most of Herantis Pharma's value examination focuses on studying past and present price action to predict the probability of Herantis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Herantis Pharma's price. Additionally, you may evaluate how the addition of Herantis Pharma to your portfolios can decrease your overall portfolio volatility.
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |